JP7008624B2 - カルボキシレート配位子修飾水酸化第二鉄コロイドおよび関連組成物を生成するための方法ならびに使用 - Google Patents

カルボキシレート配位子修飾水酸化第二鉄コロイドおよび関連組成物を生成するための方法ならびに使用 Download PDF

Info

Publication number
JP7008624B2
JP7008624B2 JP2018517847A JP2018517847A JP7008624B2 JP 7008624 B2 JP7008624 B2 JP 7008624B2 JP 2018517847 A JP2018517847 A JP 2018517847A JP 2018517847 A JP2018517847 A JP 2018517847A JP 7008624 B2 JP7008624 B2 JP 7008624B2
Authority
JP
Japan
Prior art keywords
ligand
ferric hydroxide
carboxylate
carboxylate ligand
modified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2018517847A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018530565A (ja
JP2018530565A5 (enExample
Inventor
パウエル，ジョナサン・ジョセフ
ファリア，ヌーノ・ジョルジ・ロドリゲス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
United Kingdom Research and Innovation
Original Assignee
United Kingdom Research and Innovation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by United Kingdom Research and Innovation filed Critical United Kingdom Research and Innovation
Publication of JP2018530565A publication Critical patent/JP2018530565A/ja
Publication of JP2018530565A5 publication Critical patent/JP2018530565A5/ja
Application granted granted Critical
Publication of JP7008624B2 publication Critical patent/JP7008624B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A23L33/165—Complexes or chelates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Iron (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Colloid Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP2018517847A 2015-10-09 2016-10-07 カルボキシレート配位子修飾水酸化第二鉄コロイドおよび関連組成物を生成するための方法ならびに使用 Active JP7008624B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1517893.2A GB201517893D0 (en) 2015-10-09 2015-10-09 Methods for producing carboxylate ligand modified ferric iron hydroxide colloids
GB1517893.2 2015-10-09
PCT/EP2016/074022 WO2017060441A1 (en) 2015-10-09 2016-10-07 Methods for producing carboxylate ligand modified ferric iron hydroxide colloids and related compositions and uses

Publications (3)

Publication Number Publication Date
JP2018530565A JP2018530565A (ja) 2018-10-18
JP2018530565A5 JP2018530565A5 (enExample) 2019-11-14
JP7008624B2 true JP7008624B2 (ja) 2022-01-25

Family

ID=55130824

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018517847A Active JP7008624B2 (ja) 2015-10-09 2016-10-07 カルボキシレート配位子修飾水酸化第二鉄コロイドおよび関連組成物を生成するための方法ならびに使用

Country Status (19)

Country Link
US (2) US10722459B2 (enExample)
EP (1) EP3359519B1 (enExample)
JP (1) JP7008624B2 (enExample)
CN (1) CN108430964B (enExample)
AU (1) AU2016333725B2 (enExample)
BR (1) BR112018007098B1 (enExample)
CA (1) CA3000589C (enExample)
DK (1) DK3359519T3 (enExample)
EA (1) EA035547B1 (enExample)
ES (1) ES2824452T3 (enExample)
GB (1) GB201517893D0 (enExample)
HU (1) HUE051502T2 (enExample)
MX (1) MX2018004113A (enExample)
PL (1) PL3359519T3 (enExample)
PT (1) PT3359519T (enExample)
SG (1) SG11201802770WA (enExample)
SI (1) SI3359519T1 (enExample)
WO (1) WO2017060441A1 (enExample)
ZA (1) ZA201802192B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11560339B2 (en) 2019-05-30 2023-01-24 Koch Agronomie Services, LLC Micronutrient foliar solutions
GB202005054D0 (en) 2020-04-06 2020-05-20 Nemysis Ltd Carboxylate Ligand Modified Ferric Iron Hydroxide Compositions for Use in the Treatment or Prevention of Iron Deficiency Associated with Liver Diseases
CN115196684B (zh) * 2022-07-25 2024-10-01 武汉海斯普林科技发展有限公司 一种高活性高纯氢氧化铁、制备方法及在合成对甲基苯磺酸铁中的应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010520856A (ja) 2007-02-06 2010-06-17 メディカル リサーチ カウンシル リガンド修飾ポリオキソヒドロキシ金属イオン物質、それらの使用およびそれらの調製方法
JP2011529954A (ja) 2008-08-05 2011-12-15 メディカル リサーチ カウンシル リン酸塩結合物質およびそれらの使用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3076798A (en) 1961-02-23 1963-02-05 Hausmann Lab Ltd Process for preparing a ferric hydroxide polymaltose complex
US3821192A (en) 1971-08-18 1974-06-28 Central Pharmacal Co Process for preparing an iron-saccharide complex
CN1124757A (zh) * 1994-12-31 1996-06-19 温固 速溶多羟基混合金属盐正电固溶胶制备方法
CN1121349C (zh) * 2001-10-30 2003-09-17 李国栋 一种无团聚氧化锌纳米粉体制造方法
US7994217B2 (en) 2002-05-02 2011-08-09 Xanodyne Pharmaceuticals, Inc. Prenatal multivitamin/multimineral supplement
GB0211500D0 (en) 2002-05-18 2002-06-26 Vitra Pharmaceuticals Ltd Method of forming iron hydroxypyrone compounds
DE10249552A1 (de) 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
US8093423B2 (en) 2003-02-19 2012-01-10 Globoasia, Llc Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same
TWI335218B (en) 2003-02-19 2011-01-01 Panion & Bf Biotech Inc Ferric organic compounds, uses thereof and methods of making same
US7964568B2 (en) 2003-05-30 2011-06-21 Chromaceutical Advanced Technologies, Inc. Synthesis of high molecular weight iron-saccharidic complexes
US7179939B2 (en) 2004-03-16 2007-02-20 Navinta Llc Sodium ferric gluconate complexes and method of manufacture thereof
WO2005111052A1 (de) 2004-05-17 2005-11-24 Cilag Ag Verfahren zur herstellung von eisen (iii) gluconatkomlex
ZA200702421B (en) 2004-10-08 2008-09-25 Unilever Plc Iron complex for use in the treatment and/or prevention of nutritional disorders
GB0702270D0 (en) * 2007-02-06 2007-03-14 Medical Res Council Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation
CN101691485B (zh) * 2009-07-29 2012-03-28 西南石油大学 钻井液用抗高温两性离子聚合物降滤失剂及其制备方法
CN103272553B (zh) * 2013-05-16 2015-05-13 武汉大学 一种用于除去水体中砷的磁性纳米氧化铁吸附剂的制备方法
CN103626807B (zh) * 2013-11-20 2017-07-07 青岛国风药业股份有限公司 一种多糖铁复合物的制备方法及其质量检测方法
CN103848989B (zh) * 2014-03-20 2016-06-08 南京大学 一种镍锌铁氧体/聚苯胺复合材料的制备方法
WO2015178451A1 (ja) 2014-05-23 2015-11-26 戸田工業株式会社 ヘマタイト粒子粉末の製造方法、該ヘマタイト粒子粉末を用いた塗料及び樹脂組成物

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010520856A (ja) 2007-02-06 2010-06-17 メディカル リサーチ カウンシル リガンド修飾ポリオキソヒドロキシ金属イオン物質、それらの使用およびそれらの調製方法
JP2011529954A (ja) 2008-08-05 2011-12-15 メディカル リサーチ カウンシル リン酸塩結合物質およびそれらの使用

Also Published As

Publication number Publication date
BR112018007098B1 (pt) 2023-10-10
CA3000589C (en) 2024-01-09
PL3359519T3 (pl) 2021-03-08
EP3359519B1 (en) 2020-08-12
WO2017060441A1 (en) 2017-04-13
JP2018530565A (ja) 2018-10-18
ES2824452T3 (es) 2021-05-12
HUE051502T2 (hu) 2021-03-01
AU2016333725B2 (en) 2020-10-22
ZA201802192B (en) 2020-09-30
CA3000589A1 (en) 2017-04-13
GB201517893D0 (en) 2015-11-25
MX2018004113A (es) 2018-05-17
PT3359519T (pt) 2020-10-13
CN108430964A (zh) 2018-08-21
HK1253078A1 (en) 2019-06-06
US20180271784A1 (en) 2018-09-27
SI3359519T1 (sl) 2021-03-31
CN108430964B (zh) 2021-05-11
US11684572B2 (en) 2023-06-27
US20200155453A1 (en) 2020-05-21
EA201890601A1 (ru) 2018-11-30
US10722459B2 (en) 2020-07-28
SG11201802770WA (en) 2018-05-30
EA035547B1 (ru) 2020-07-06
DK3359519T3 (da) 2020-09-07
AU2016333725A1 (en) 2018-04-26
BR112018007098A2 (pt) 2019-01-15
EP3359519A1 (en) 2018-08-15

Similar Documents

Publication Publication Date Title
JP5805532B2 (ja) リン酸塩結合物質およびそれらの使用
KR101951857B1 (ko) 마그헤마이트 또는 마그헤마이트/마그네타이트에 기초한 나노미립자 인산염 흡착제, 이의 제법 및 용도
JP5756598B2 (ja) リガンド修飾ポリオキソヒドロキシ金属イオン物質、それらの使用およびそれらの調製方法
US11684572B2 (en) Methods for producing carboxylate ligand modified ferric iron hydroxide colloids and related compositions and uses
CN101627047B (zh) 配体改性的聚氧金属离子材料，它们的应用及用于它们的制备方法
KR20150078375A (ko) 철산화물 나노입자를 포함하는 철결핍증의 예방 또는 치료용 약학 조성물
JP7033545B2 (ja) 配位子修飾及び配位子コーティングされた水酸化第二鉄からマルトール第二鉄組成物を生成するための方法
US12329736B2 (en) Carboxylate ligand modified ferric iron hydroxide compositions for use in the treatment or prevention of iron deficiency associated with liver diseases
HK1253078B (en) Methods for producing carboxylate ligand modified ferric iron hydroxide colloids and related compositions and uses
HK40087350A (en) Carboxylate ligand modified ferric iron hydroxide compositions for use in the treatment or prevention of iron deficiency associated with liver diseases
HK40087350B (en) Carboxylate ligand modified ferric iron hydroxide compositions for use in the treatment or prevention of iron deficiency associated with liver diseases

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20190408

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20190408

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20191007

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20191007

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200826

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20201126

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20210330

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210730

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20210730

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20210810

C21 Notice of transfer of a case for reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C21

Effective date: 20210811

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210909

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20211209

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20211227

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20220111

R150 Certificate of patent or registration of utility model

Ref document number: 7008624

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250